SCHEMBL2045884

SCHEMBL2045884

Cc1cc(C)c(N2CCN(c3c(C)cc(C)cc3C)C2=c2ncccc2=Cc2ccccc2)c(C)c1.Cl[Ru]Cl

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2045882 0.94 MEN1 (0.32) MEN1GAAKMT2A
SCHEMBL31258313 0.74 KDM4E (0.33)
SCHEMBL13238426 0.71 MAPT (0.39) MEN1KMT2A
SCHEMBL28059372 0.66 TACR1 (0.33) MEN1KMT2A
SCHEMBL30485195 0.65 HPGD (0.32)
SCHEMBL2882672 0.65 ALDH1A1 (0.33) MEN1KMT2A
Hydrochloric Acid SCHEMBL3670743 0.65 CRHR1 (0.33) MEN1KMT2A
SCHEMBL31258311 0.64
Hydrochloric Acid SCHEMBL3670747 0.64 ALDH1A1 (0.32) MEN1KMT2A
SCHEMBL23216998 0.63 CRHR1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125499-A1 CATALYST LIQUID AND POLYMERIZABLE COMPOSITION RIMTEC CORPORATION (JP) 2026-05-07 US disclosed
US-20260125501-A1 POLYMERIZABLE COMPOSITION AND NORBORNENE RESIN RIMTEC CORPORATION (JP) 2026-05-07 US disclosed
EP-4606836-A1 CATALYST LIQUID AND POLYMERIZABLE COMPOSITION RIMTEC Corporation (JP) 2025-08-27 EP disclosed
EP-4606837-A1 POLYMERIZABLE COMPOSITION AND NORBORNENE RESIN RIMTEC Corporation (JP) 2025-08-27 EP disclosed
EP-2653501-B1 CROSSLINKABLE RESIN MOLDED BODY, AND LAMINATE ZEON CORP (JP) 2019-05-22 EP disclosed
US-9601726-B2 Sealing material for secondary battery and sealing material composition for secondary battery ZEON CORPORATION (JP) 2017-03-21 US disclosed
EP-2620483-B1 ADHESIVE FILM FOR ORGANIC ELECTROLYTE ACCUMULATOR DEVICES ZEON CORP (JP) 2016-02-10 EP disclosed
US-20150188099-A1 SEALING MATERIAL FOR SECONDARY BATTERY AND SEALING MATERIAL COMPOSITION FOR SECONDARY BATTERY ZEON CORPORATION (JP) 2015-07-02 US disclosed
US-8759463-B2 Cross-linkable resin shaped article, cross-linked resin shaped article and laminate ZEON CORPORATION (JP) 2014-06-24 US disclosed
EP-2653501-A1 CROSSLINKABLE RESIN MOLDED BODY, CROSSLINKED RESIN MOLDED BODY, AND LAMINATE Zeon Corporation (JP) 2013-10-23 EP disclosed
US-20130267672-A1 CROSS-LINKABLE RESIN SHAPED ARTICLE, CROSS-LINKED RESIN SHAPED ARTICLE AND LAMINATE ZEON CORPORATION (JP) 2013-10-10 US disclosed
EP-2620483-A1 ADHESIVE FILM FOR ORGANIC ELECTROLYTE ACCUMULATOR DEVICES Zeon Corporation (JP) 2013-07-31 EP disclosed
US-20130183519-A1 ADHESIVE FILM FOR ORGANIC ELECTROLYTE-TYPE ENERGY STORAGE DEVICE ZEON CORPORATION (JP) 2013-07-18 US disclosed
US-7964685-B2 Polymerizable composition ZEON CORPORATION (JP) 2011-06-21 US disclosed
US-20100144924-A1 POLYMERIZABLE COMPOSITION ZEON CORPORATION (JP) 2010-06-10 US disclosed
EP-2098550-A1 POLYMERIZABLE COMPOSITION ZEON CORPORATION (JP) 2009-09-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125499-A1 CATALYST LIQUID AND POLYMERIZABLE COMPOSITION TCP1, ROS1, PEAK1 MEN1 1052/4885GAA 4110/4885KMT2A 3300/4885
US-20260125501-A1 POLYMERIZABLE COMPOSITION AND NORBORNENE RESIN REV1, RER1, LCP1 MEN1 2043/4885GAA 4332/4885KMT2A 3126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.